161: $148,000,000
#SistersInLaw
00:00
Review of FDA Approval and Standing to Bring the Case
This chapter discusses the review of a court decision regarding the FDA approval of a drug, Miffer-Pristone, and the standing of a group of doctors who oppose the approval. The chapter explores the potential impact of the case on the administrative state and the nationwide availability of abortion.
Play episode from 55:36
Transcript
